MNPR · Monopar Therapeutics Inc

-

-

Please sign in to comment on MNPR

1 Comment

Admin
4 years ago

Monopar Therapeutics Inc is currently in a long term downtrend where the price is trading 7.0% below its 200 day moving average.

From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.

Monopar Therapeutics Inc's total revenue sank by nan% to $0 since the same quarter in the previous year.

Its net income has dropped by 522395059.7% to $-6T since the same quarter in the previous year.

Finally, its free cash flow fell by 85.5% to $-1M since the same quarter in the previous year.

Based on the above factors, Monopar Therapeutics Inc gets an overall score of 1/5.












© PyInvesting 2025

About    Blog    Influencers   Careers   Contact Us   Disclaimer   Privacy Policy